Editorial: drug monitoring targets for optimising adalimumab in Crohn's disease
- PMID: 25185733
- DOI: 10.1111/apt.12911
Editorial: drug monitoring targets for optimising adalimumab in Crohn's disease
Comment on
-
Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease.Aliment Pharmacol Ther. 2014 Sep;40(6):620-8. doi: 10.1111/apt.12869. Epub 2014 Jul 15. Aliment Pharmacol Ther. 2014. PMID: 25039584 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical